www.elsevier.com/locate/yabbi
0003-9861/$ - see front matter © 2006 Elsevier Inc. All rights reserved. doi:10.1016/j.abb.2006.09.004
Identi
Wcation of novel hydroxysteroid-sulfating cytosolic
SULTs, SULT2 ST2 and SULT2 ST3, from zebra
Wsh:
Cloning, expression, characterization, and developmental expression
Shin Yasuda
a
, Ming-Yih Liu
b
, Yuh-Shyong Yang
c
, Rhodora Snow
d
,
Saki Takahashi
a
, Ming-Cheh Liu
a,¤
a Biomedical Research Center, The University of Texas Health Center, Tyler, TX 75708, USA b National Synchrotron Radiation Research Center, Hsinchu, Taiwan, ROC
c Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan, ROC d Department of Chemistry, Jarvis Christian College, Hawkins, TX 75765, USA
Received 2 June 2006, and in revised form 18 August 2006 Available online 25 September 2006
Abstract
By searching the expressed sequence tag database, two zebra
Wsh cDNAs encoding putative cytosolic sulfotransferases (SULTs) were
identi
Wed. Sequence analysis indicated that these two zebraWsh SULTs belong to the cytosolic SULT2 gene family. The recombinant form
of these two novel zebra
Wsh SULTs, designated SULT2 ST2 and SULT2 ST3, were expressed using the pGEX-2TK glutathione
S-trans-ferase (GST) gene fusion system and puri
Wed from transformed BL21 (DE3) Escherichia coli cells. PuriWed GST-fusion protein form of
SULT2 ST2 and SULT2 ST3 exhibited strong sulfating activities toward dehydroepiandrosterone (DHEA) and corticosterone,
respec-tively, among various endogenous compounds tested as substrates. Both enzymes displayed pH optima at »6.5. Kinetic constants of the
two enzymes, as well as the GST-fusion protein form of the previously identi
Wed SULT2 ST1, with DHEA and corticosterone as
sub-strates were determined. Developmental stage-dependent expression experiments revealed distinct patterns of expression of SULT2 ST2
and SULT2 ST3, as well as the previously identi
Wed SULT2 ST1, during embryonic development and throughout the larval stage onto
maturity.
© 2006 Elsevier Inc. All rights reserved.
Keywords: Sulfotransferase; SULT; Sulfation; Dehydroepiandrosterone; Corticosterone; Molecular cloning; Developmental expression; ZebraWsh
The cytosolic sulfotransferases (SULTs) in mammals
and other vertebrates constitute a group of enzymes that
catalyze the transfer of a sulfonate group from the active
sulfate, 3
⬘-phosphoadenosine 5⬘-phosphosulfate (PAPS)
[1]
, to substrate compounds containing hydroxyl or amino
groups
[2–5]
. Such sulfation reactions are generally thought
to serve for detoxi
Wcation of xenobiotics, as well as
bio-transformation of endogenous compounds such as steroid
and thyroid hormones, catecholamines, cholesterol, and
bile acids
[2–5]
. Based on amino acid sequence homology,
all cytosolic SULTs from vertebrate animals are proposed
to constitute a gene superfamily, and distinct gene families
have been further categorized
[6]
. Two major gene families
among them are the phenol SULT
1family (designated
SULT1) and hydroxysteroid SULT family (designated
SULT2)
[6–8]
. The hydroxysteroid SULT (SULT2) family
presently comprises two sub-families,
dehydroepiandroster-one (DHEA) SULT (SULT2A) and cholesterol/pregnenoldehydroepiandroster-one
* Corresponding author. Fax: +1 903 877 2863.
E-mail address: [email protected] (M.-C. Liu).
1 Abbreviations used: SULT, sulfotransferase; PAPS, 3 ⬘-phosphoadeno-sine 5⬘ phosphosulfate; RT-PCR, reverse transcription-polymerase chain reaction; 3⬘-RACE, 3⬘-rapid ampliWcation of cDNA ends; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
SULT (SULT2B). Members of the hydroxysteroid SULT
family are involved in the sulfation of both endogenous and
exogenous steroids, which has been suggested to be an
important mechanism for the homeostasis, bioactivation/
inactivation, or transport of these compounds in vivo
[9]
.
How the hydroxysteroid-sulfating cytosolic SULT enzymes
function to regulate the activity of steroids, as well as their
metabolism and homeostasis, however, remains to be fully
elucidated. Moreover, only fragmentary information is
available concerning the cell type/tissue/organ-speci
Wc
expression of these hydroxysteroid-sulfating SULTs, and
very little is known with regard to the ontogeny of these
enzymes.
ZebraWsh has in recent years emerged as a popular
ani-mal model for a wide range of studies
[10,11]
. Its
advanta-ges, compared with mouse, rat, or other vertebrate animal
models, include the small size, availability of a relatively
large number of eggs, rapid development externally of
vir-tually transparent embryos, and short generation time.
These unique characteristics make the zebraWsh an
excel-lent model for a systematic investigation of the ontogeny,
cell type/tissue/organ-speciWc expression, and physiological
involvement of individual cytosolic SULTs. A prerequisite
for using the zebra
Wsh in these studies, however, is the
iden-ti
Wcation of the various cytosolic SULTs and their
func-tional characterization. We have recently embarked on the
molecular cloning of zebra
Wsh cytosolic SULTs
[12–18]
.
Sequence analysis via BLAST search revealed that the
zebra
Wsh cytosolic SULTs we have cloned
[12–18]
display
sequence homology to mammalian cytosolic SULTs. Of the
eight zebra
Wsh cytosolic SULTs that have been cloned, six
fall within the SULT1 gene family
[12,13,16–18]
, one
belongs to the SULT2 gene family
[14]
, and one appears to
be independent from all known SULT gene families
[15]
.
The zebra
Wsh SULT2 enzyme (now designated SULT2
ST1) previously cloned and expressed displayed sulfating
activities toward several steroids including DHEA,
preg-nenolone, allopregnanolone, 4-androstene 3,17-dione, and
17-hydroxypregnenolone
[14]
. Whether additional SULT2
enzymes, dedicated to the sulfation of other
hydroxyster-oids, exist in zebraWsh remained an open question.
We report here the identiWcation of two novel zebraWsh
cytosolic SULT2 enzymes, designated SULT2 ST2 and
SULT2 ST3. Their enzymatic activities toward a variety of
endogenous compounds and xenobiotics were examined.
Kinetic parameters of the two enzymes in catalyzing the
sulfation of DHEA and corticosterone were determined.
Moreover, their developmental stage-dependent expression
during embryogenesis onto maturity was investigated.
Materials and methods
Materials
DHEA, 17-estradiol, estrone, acetaminophen, bisphenol A, butylated hydroxyanisole, butylated hydroxytoluene, caVeic acid, catechin, chloro-genic acid, daidzein, diethylstilbestrol, L-3,4-dihydroxyphenylalanine (L-Dopa), D-Dopa, dopamine, epicatechin, epigallocatechin gallate, 17
-eth-ynylestradiol, gallic acid, genistein, hydrocortisone, minoxidil, myricetin, -naphthylamine, -naphthol, p-nitrophenol, n-nonylphenol, n-octylphe-nol, n-propyl gallate, quercetin, L-thyronine, 3,3⬘,5-triiodo-L-thyronine, aprotinin, thrombin, adenosine 5⬘-triphosphate (ATP), sodium dodecyl sulfate (SDS), sodium acetate, 2-morpholinoethanesulfonic acid (MES), 3-(N-morpholino)propanesulfonic acid (MOPS),
N-2-hydroxylpiperazine-N⬘-2-ethanesulfonic acid (HEPES), 3-[N-tris-(hydroxymethyl)methyla-mino]-propanesulfonic acid (TAPS), 2-(cyclohexylamino)ethanesulfonic acid (CHES), 3-(cyclohexylamino)-1-propanesulfonic acid (CAPS), Tri-zma base, dithiothreitol (DTT), and isopropyl -D-thiogalactopyranoside (IPTG) were products of Sigma Chemical Company. TRI Reagent was from Molecular Research Center, Inc. Unfertilized zebraWsh eggs, embryos and larvae at diVerent developmental stages were prepared by ScientiWc Hatcheries. Total RNA from a 3-month-old zebraWsh was pre-pared as described previously [13]. Taq DNA polymerase was a product of Promega Corporation. Takara Ex Taq DNA polymerase was purchased from PanVera Corporation. T4 DNA ligase and BamHI restriction endo-nuclease were from New England Biolabs. Oligonucleotide primers were synthesized by MWG Biotech. pSTBlue-1 AccepTor Vector Kit and BL21 (DE3) competent cells were from Novagen. Prestained protein molecular weight standard were from Life Technologies. pGEX-2TK glutathione S-transferase (GST) gene fusion vector, GEX-5⬘ and GEX-3⬘ sequencing primers, and glutathione–Sepharose 4B were products of Amersham Bio-sciences. GST-fusion protein form of the previously identiWed zebraWsh SULT2 ST1 [14] was expressed and puriWed based on the same procedure
described below for SULT2 ST2 and ST3. Recombinant human bifunc-tional ATP sulfurylase/adenosine 5⬘-phosphosulfate kinase was prepared as described previously [19]. Cellulose thin-layer chromatography (TLC) plates were products of EM Science. Carrier-free sodium [35S]sulfate, Eco-lume scintillation cocktail, corticosterone, pregnenolone, 4-androsterone-3,17-dione, hydrocortisone, progesterone, 17-hydroxyprogesterone, and 17-hydroxypregnenolone were from ICN Biomedicals. Allopregnanolone was from Calbiochem. All other reagents were of the highest grades commercially available.
Cloning, bacterial expression, and puri
Wcation of recombinant
zebra
Wsh cytosolic SULT2 ST2 and ST3
By searching the expressed sequence tag database, two zebraWsh cDNAs (GenBank Accession Nos. CD014163 (SULT2 ST2) and BQ132464 (SULT2 ST3)) encoding putative cytosolic SULTs were identi-Wed. These two cDNAs, obtained from Open Biosystems, were subjected to nucleotide sequencing [20]. To subclone the two cDNAs for expression, sense and antisense oligonucleotide primers designed based on 5⬘- and 3⬘-coding regions of the nucleotide sequences determined were synthesized with BamHI restriction site incorporated at the end (see Table 1). Using these primer sets, PCRs were carried out under the action of EX Taq DNA polymerase, with the two commercially obtained cDNAs as templates. AmpliWcation conditions were 2 min at 94 °C and 20 cycles of 94 °C for 35 s, 60 °C for 40 s, 72 °C for 1 min. The Wnal reaction mixtures were applied onto a 1.2% agarose gel, separated by electrophoresis, and visual-ized by ethidium bromide staining. The PCR product bands detected were excised from the gel, and the DNAs therein were isolated by spin Wltration. PuriWed PCR products were subjected to BamHI restriction and cloned into BamHI-restricted pGEX-2TK vector, and veriWed for authenticity by nucleotide sequencing [20]. To express the recombinant zebraWsh SULT2
ST2 and ST3, competent Escherichia coli BL21 (DE3) cells, transformed with pGEX-2TK harboring the cDNA encoding SULT2 ST2 or ST3, were grown in 1 L LB medium supplemented with 60g/ml ampicillin. After the cell density reached 0.6 OD600 nm, IPTG at a Wnal concentration of 0.1 mM was added to induce the production of recombinant zebraWsh SULT. After an overnight induction at room temperature, the cells were collected by centrifugation and homogenized in 25 ml ice-cold lysis buVer (10 mM Tris–HCl, pH 8.0, 150 mM NaCl, and 1 mM EDTA) using an Aminco French Press. Twenty microliters of 10 mg/ml aprotinin (a protease inhibi-tor) was added to the crude homogenate. The crude homogenate was sub-jected to centrifugation at 10,000g for 15 min at 4 °C. The supernatant collected was fractionated using 2.5 ml of glutathione–Sepharose, and the
bound GST-fusion protein was either eluted by an elution buVer (50 mM Tris–HCl, pH 8.0, plus 10 mM reduced glutathione) at 4 °C or treated with 3 ml of a thrombin digestion buVer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, and 2.5 mM CaCl2) containing 5 U/ml bovine thrombin at room temperature. Following a 10 to 15-min incubation with constant agitation, the preparation was subjected to centrifugation. The recombinant zebraWsh SULT (in GST-fusion protein form or free (thrombin-cleaved) form) present in the supernatant collected was analyzed for purity by SDS–polyacrylamide gel electrophoresis (SDS–PAGE) and subjected to enzymatic characterization.
Enzymatic assay
The sulfating activity of the recombinant zebraWsh cytosolic SULTs was assayed using radioactive PAP[35S] as the sulfate donor. The standard assay mixture, with a Wnal volume of 25 l, contained 50 mM Mops buVer at pH 7.0 (for SULT2 ST2 and ST3) or Ches at pH 9.5 (for SULT2 ST1), 14M PAP[35S] (15 Ci/mmol), 1 mM DTT, and 50M substrate. Controls with DMSO or water, in place of substrate, were also prepared. The reac-tion was started by the addireac-tion of the enzyme, allowed to proceed for 5 min at 28 °C, and terminated by heating at 100 °C for 2 min. The precipi-tates formed were cleared by centrifugation, and the supernatant was sub-jected to the analysis of [35S]sulfated product using the previously developed TLC procedure [21], with n-butanol/isopropanol/88% formic acid/water (3:1:1:1; by volume) as the solvent system. To examine the pH-dependence of the sulfation of DHEA or corticosterone, diVerent buVers (50 mM sodium acetate at 4.5, 5.0, or 5.5; Mes at 5.5, 6.0, or 6.5; Mops at 6.5, 7.0, or 7.5; Hepes at 7.0, 7.5 or 8.0; Taps at 8.0, 8.5 or 9.0; Ches at 9.0, 9.5, or 10.0; and Caps at 10.0, 10.5, 11.0 or 11.5), instead of 50 mM Mops (pH 7.0), were used in the reactions. For the kinetic studies on the sulfation of DHEA and corticosterone, varying concentrations of these substrate compounds and 50 mM Mops buVer at pH 7.0 (for SULT2 ST2 and ST3) or Ches at pH 9.5 (for SULT2 ST1) were used.
Analysis of the developmental stage-dependent expression of the
zebra
Wsh cytosolic SULT2 STs
RT-PCR was employed to investigate the developmental stage-depen-dent expression of the zebraWsh cytosolic SULT2 ST2 and ST3, as well as the previously identiWed SULT2 ST1. Total RNAs from zebraWsh embryos, larvae, and adult (male or female) Wsh at diVerent developmental stages were isolated using TRI Reagent, based on manufacturer’s
instruc-tions. Aliquots containing 5g each of the total RNA preparations were used for the synthesis of the Wrst-strand cDNA using the First-Strand cDNA Synthesis Kit (Amersham Biosciences). One microliter aliquots of the 33l Wrst-strand cDNA solutions prepared were used as the template for the subsequent PCR ampliWcation. PCRs were carried out in 25 l reaction mixtures using EX Taq DNA polymerase, in conjunction with gene-speciWc sense and antisense oligonucleotide primers (see Table 1). AmpliWcation conditions were 2 min at 94 °C followed by 40 cycles of 30 s at 94 °C, 40 s at 60 °C, and 1 min at 72 °C. The Wnal reaction mixtures were applied onto a 1.2% agarose gel, separated by electrophoresis, and visual-ized by ethidium bromide staining. As a control, PCR ampliWcation of the sequence encoding zebraWsh -actin was concomitantly performed using the above-mentioned Wrst-strand cDNAs as templates, in conjunction with gene-speciWc sense and antisense oligonucleotide primers (Table 1) designed based on reported zebraWsh -actin nucleotide sequence (GenBank Accession No. AF057040).
Miscellaneous methods
PAP[35S] was synthesized from ATP and carrier-free [35S]sulfate using the bifunctional human ATP sulfurylase/APS kinase and its purity deter-mined as previously described [22,23]. The PAP[35S] synthesized was adjusted to the required concentration and speciWc activity by the addition of cold PAPS. SDS–PAGE was performed on 12% polyacrylamide gels using the method of Laemmli [24]. Protein determination was based on the method of Bradford [25] with bovine serum albumin as the standard.
Results and discussion
In vertebrates, the sulfation of steroids by the cytosolic
hydroxysteroid SULTs, belonging to the SULT2 gene
fam-ily
[6]
, is recognized as an important regulatory pathway for
the homeostasis as well as bioactivation/inactivation of
these compounds
[9]
. As a part of an e
Vort to develop a
zebra
Wsh model for investigating in greater detail the
func-tional involvement of the hydroxysteroid SULTs, we had
previously cloned, expressed and characterized a zebra
Wsh
DHEA-sulfating SULT2 (now designated SULT2 ST1)
[14]
. In view of the diversity of SULT2 enzymes in other
vertebrates including human and mouse
[6,26]
, we
specu-Table 1
Oligonucleotide primers used for the cDNA cloning of zebraWsh SULT2 ST2 and ST3 and for the RT-PCR analysis of the developmental stage-dependent expression of the SULT2 STs
a Recognition sites of BamHI restriction endonuclease in the oligonucleotides are underlined. Initiation and termination codons for translation are in bold type.
b The sense and antisense oligonucleotide primer sets listed were veriWed by BLAST Search to be speciWc for the target zebraWsh SULT2 or -actin nucleotide sequence.
Target sequence Sense and antisense oligonucleotide primers used
I. For cDNA cloninga:
SULT2 ST2 Sense: 5⬘-CGCGGATCCATGACTGAATCGGAGCTGTA-3⬘
Antisense: 5⬘-CGCGGATCCTCAGTCCCATGGAAACTTGAA-3⬘
SULT2 ST3 Sense: 5⬘-CGCGGATCCATGGAGGTCAGCGAATTCAAT-3⬘
Antisense: 5⬘-CGCGGATCCTTATTCCTCATCCCAGGGGAATTT-3⬘
II. For RT-PCR analysisb:
SULT2 ST1 Sense: 5⬘-ACAAAACCGCAGTCGCTGCACAGAACCGGT-3⬘
Antisense: 5⬘-TGATACAGATAAACATCACTATTACTGTGG-3⬘
SULT2 ST2 Sense: 5⬘-TGCAGCTGCTCTCTAGATTAATTCTTCATT-3⬘
Antisense: 5⬘-TTTTTGGCTGTGCACCAAATGTTTATTAGAA-3⬘
SULT2 ST3 Sense: 5⬘-GAACTCTTTGCACAAAACTACCTAGTTTTCCCA-3⬘
Antisense: 5⬘-GGACAGACTGAAGAACTCCACCTTAACCAA-3⬘
-Actin Sense: 5⬘-ATGGATGAGGAAATCGCTGCCCTGGTC-3⬘
lated that additional SULT2 enzymes may be present in
zebra
Wsh. Here, we report the identiWcation,
characteriza-tion and ontogeny of two novel zebra
Wsh cytosolic SULT2
enzmes, designated SULT2 ST2 and ST3.
Molecular cloning of the zebra
Wsh cytosolic SULT2 ST2 and
ST3
By searching the expressed sequence tag database, two
zebra
Wsh cDNAs (GenBank Accession No. CD014163
(SULT2 ST2) and BQ132464 (SULT2 ST3)) encoding
putative cytosolic SULTs were identi
Wed. These two
cDNAs, obtained commercially, were subjected to
nucleo-tide sequencing
[20]
. The nucleotide sequences obtained
were submitted to the GenBank database under the
Acces-sion No. DQ640387 for SULT2 ST2 and DQ640388 for
SULT2 ST3.
Fig. 1
shows the alignment of the deduced
amino acid sequence of the two newly cloned zebraWsh
SULT2 STs. The open reading frame of the SULT2 ST2
encompasses 864 nucleotides and codes for a 287-amino
acid polypeptide, and that of the SULT2 ST3 contains 867
nucleotides and encodes a 288-amino acid polypeptide.
Similar to other cytosolic SULTs, these two new zebraWsh
SULTs contains sequences resembling the so-called
“signa-ture sequences” (YPKSGTxW in the N-terminal region
and RKGxxGDWKNxFT in the C-terminal region; as
underlined) characteristic of SULT enzymes
[8]
. Of these
two sequences, YPKSGTxW has been demonstrated by
X-ray crystallography to be responsible for binding to the
5
⬘-phosphosulfate group of PAPS, a co-substrate for
SULT-catalyzed sulfation reactions
[27]
, and thus
desig-nated the “5
⬘-phosphosulfate binding (5⬘-PSB) motif”
[28]
.
The cloned zebra
Wsh SULT also contains the
“3⬘-phos-phate binding (3
⬘-PB) motif” (amino acid residues 187–197;
as underlined) responsible for the binding to the 3
⬘-phos-phate group of PAPS
[28]
. Sequence analysis based on a
BLAST Search revealed that the deduced amino acid
sequence of the zebra
Wsh SULT2 ST2 displays 43 and 40%
identity to human SULT2B1a and SULT2A1, and lower %
identity to other known SULTs. The deduced amino acid
sequence of the zebra
Wsh SULT2 ST3 displays 49% identity
to human SULT2B1a and SULT2B1b, and lower %
iden-tity to other known SULTs. It is generally accepted that
members of the same SULT gene family share at least 45%
amino acid sequence identity, and members of subfamilies
further divided in each SULT gene family are greater than
60% identical in amino acid sequence
[6–8]
. Based on these
criteria, both the zebra
Wsh SULT2 STs appear to belong to
the SULT2 gene family, and are designated the zebra
Wsh
SULT2 ST2 and ST3 in accordance with the nomenclature
used in ZFIN database (cf. the dendrogram shown in
Fig. 2
). It is interesting to note that the newly cloned
zebraWsh SULT2 ST2 and ST3 displays, respectively, 87.5
and 52.6% amino acid sequence identity to the previously
identiWed zebraWsh SULT2 ST1
[14]
.
Expression, puriWcation, and characterization of recombinant
zebraWsh cytosolic SULT2 ST2 and ST3
The coding region of the zebraWsh SULT2 ST2 or ST3
cDNA was subcloned into pGEX-2TK, a prokaryotic
expression vector, for the expression of recombinant
enzyme in E. coli. As shown in
Fig. 3
, the GST-fusion
pro-tein form of the recombinant zebraWsh SULT2 ST2 (lane 1)
and ST3 (lane 3), puriWed from the E. coli extract, migrated
at »58 kDa position upon SDS–PAGE. Upon thrombin
digestion, the free form of SULT ST2 (lane 2) and ST3
(lane 4) migrated as »33 kDa proteins (
Fig. 3
). This is in
agreement with the molecular weight (32,000–35,000)
gen-erally found for cytosolic SULTs
[1–3]
. It was subsequently
noted that the thrombin-digested zebra
Wsh SULT2 ST2
and ST3 exhibited lower and unstable sulfating activity in
comparison with the GST-fusion protein form of these two
enzymes (data not shown). The GST-fusion protein form of
both zebra
Wsh SULT2 STs, therefore, was used for the
enzymatic characterization. (The speci
Wc activities
deter-Fig. 1. Alignment of the deduced amino acid sequences of the zebraWsh SULT2 ST1, ST2, and ST3. Residues conserved between the two enzymes are boxed. Two “signature sequences,” respectively, located in the N- and C-terminal regions, as well as a conserved sequence in the middle region are under-lined. The percent numbers in parentheses refer to the percent amino acid identities to the SULT2 ST1 sequence.
mined in the following studies were corrected for the
molec-ular mass of the GST moiety in the fusion protein form of
the enzymes.) A pilot experiment Wrst revealed that the
SULT2 ST2 and ST3 exhibited strong activity toward
DHEA and corticosterone, respectively. A pH-dependence
experiment subsequently performed showed that the
SULT2 ST2 with DHEA as substrate (
Fig. 4
A) and ST3
with corticosterone as substrate (
Fig. 4
B) both exhibited
optimum activity at pH 6.5. It is interesting to note that the
previously identiWed SULT2 ST1, while sharing a high
degree of sequence homology (87.5% amino acid identity)
with the SULT2 ST2, displayed a pH optimum at 9.5
[14]
.
Representative endogenous and xenobiotic compounds
were tested as substrates for these enzymes, as well as the
GST-fusion protein form of the previously identiWed
SULT2 ST1. The activity data obtained are compiled in
Table 2
. Among the compounds we tested, the zebraWsh
SULT2 ST2 and ST3 displayed strongest sulfating activities
toward DHEA (at 579 pmol/min/mg enzyme) and
cortico-sterone (at 510 pmol/min/mg enzyme), respectively. In
addi-tion, SULT2 ST2 also showed sulfating activities toward
pregnenolone, 17
-estradiol and estrone; and SULT2 ST3
displayed activities toward pregnenolone, 17
-estradiol,
DHEA and allopregnanolone. Neither enzyme, however,
exhibited detectable activities toward other endogenous
compounds including
L-Dopa, dopamine,
4-androstene-3,17-dione, hydrocortisone, 17
-hydroxypregnenolone,
17
-hydroxyprogesterone, progesterone,
L-thyroxine, and
L-triiodothyronine, and exogenous compounds including
acetaminophen, bisphenol A, n-nonylphenol,
n-octylphe-nol, p-nitrophen-octylphe-nol, -naphthol, -naphthylamine, butylated
hydroxyanisole, caVeic acid, catechin, epicatechin, gallic
acid, chlorogenic acid, daidzein, genistein, myricetin,
quer-cetin, n-propyl gallate, and minoxidil. That both SULT2
ST2 and ST3 exhibited sulfating activities toward
exclu-sively hydroxysteroids is in line with these enzymes being
Fig. 2. ClassiWcation of the zebraWsh SULT2 ST2 and ST3 on the basis of their amino acid sequences. The dendrogram shows the degree of amino acid sequence homology among cytosolic SULTs. For references for individual SULTs, see the review by Blanchard et al. [6]. h, human; m, mouse; and zf, zebraWsh. The dendrogram was generated based on Greedy algorithm [42,43].
mSULT2B1 hSULT2B1a mSULT2A1 mSULT2A2 mSULT1C1 hSULT2A1 mSULT1E1 hSULT1A3 hSULT1A2 hSULT1A1 hSULT1C3 hSULT1C2 hSULT1E1 mSULT1B1 hSULT1B1 mSULT1D1 mSULT1A1
SULT1
SULT2
zfSULT2 ST3 zfSULT2 ST2 zfSULT1 ST4 zfSULT1 ST3 zfSULT1 ST2 zfSULT1 ST1 zfSULT1 ST6 zfSULT1 ST5 zfSULT2 ST1Fig. 3. SDS gel electrophoretic pattern of the puriWed recombinant zebraWsh SULT2 ST2 and ST3. PuriWed zebraWsh SULT samples were subjected to SDS–PAGE on a 12% gel, followed by Coomassie blue stain-ing. Samples analyzed in lanes 1 and 2 were, respectively, GST-fusion pro-tein and thrombin-digested forms of SULT2 ST2. Samples in lanes 3 and 4 were GST-fusion protein and thrombin-digested forms of SULT2 ST3. Protein molecular weight markers co-electrophoresed are: lysozyme (MrD14,300), -lactoglobulin (MrD18,400), carbonic anhydrase (MrD29,000), ovalbumin (MrD43,000), bovine serum albumin (MrD68,000), phosphorylase b (MrD97,400), and myosin (H-chain) (MrD200,000).
1
2
M
- 97.4 kDa - 68 kDa - 43 kDa - 29 kDa - 18.4 kDa - 14.3 kDa - 200 kDa3
4
members of the SULT2 gene family. Compared with the
highly homologous SULT2 ST2, the previously identiWed
SULT2 ST1 exhibited sulfating activities toward DHEA,
pregnenolone, 17
-estradiol, allopregnanolone,
4-andro-stene-3,17-dione and 17
-hydroxypregnenolone, but not
estrone (
Table 2
). The three zebra
Wsh SULT2 enzymes
identi
Wed to date therefore appeared to sulfate distinct,
albeit overlapping, groups of hydroxysteroids. Whether
their distinct substrate speci
Wcity may reXect the diVerential
functional involvement of the three enzymes in vivo remains
to be clari
Wed.
The kinetics of the sulfation of DHEA by SULT2 ST1
and ST2 and the sulfation of corticosterone by SULT2
ST3 were further examined. Data obtained were processed
using the Excel program to generate the best
Wtting
trend-lines for the Lineweaver–Burk double-reciprocal plots.
Table 3
shows the kinetic constants determined for the
sulfation of DHEA by SULT2 ST1 and SULT2 ST2, as
well as the sulfation of corticosterone by ST3. The K
mval-ues of SULT2 ST1 and SULT2 ST2 with DHEA and ST3
with corticosterone were 102, 177, and 101
M,
respec-tively. TheseK
mvalues are considerably higher than those
previously determined for the sulfation of DHEA,
choles-terol or pregnenolone by human SULT2A1, SULT2B1a
or SULT2B1b
[29–31]
. It is possible that the high K
mval-ues of SULT2 ST1, ST2, and ST3 may represent
adapta-tion to high steroid concentraadapta-tions that might be present
systematically or locally in zebra
Wsh. Previous studies
have revealed circulating levels of some hydroxysteroids
in
Wsh to be in M concentration ranges
[32,33]
, which are
considerably higher than those found in humans (sub-nM
to nM)
[34]
. Moreover, it has been demonstrated that
physiological levels of hydroxysteroids may increase
dra-matically in response to aquatic environmental stimuli
[32,35,36]
. Another possibility is that certain
yet-unidenti-Wed co-factors or mechanisms may exist for the regulation
Fig. 4. pH dependency of the sulfating activity of the zebraWsh SULT2 ST2 with DHEA (A) and ST3 with corticosterone (B) as a substrate. The enzymatic assays were carried out under standard assay conditions as described under Materials and methods, using diVerent buVer systems as indicated. The data represent calculated mean § standard deviation derived from three experiments.
0 100 200 300 400 500 600 700 0 100 200 300 400 500 600
A
B
4 5 6 7 8 9 10 11 12 4 5 6 7 8 9 10 11 12 pH Specif ic Acti vity (pmol/min/mg) Specif ic Acti vity (pmol/min/mg) pH Table 2SpeciWc activities of the zebraWsh SULT2 ST1, ST2, and ST3 with endogenous compounds as substratesa
a SpeciWc activity refers to pmol substrate sulfated/min/mg puriWed enzyme. Data represent means § SD derived from three experiments. b SpeciWc activity determined is lower than the detection limit (estimated to be »10 pmol/min/mg protein).
SpeciWc activity (pmol/min/mg)
SULT2 ST1 SULT2 ST2 SULT2 ST3
Dehydroepiandrosterone (DHEA) 554 § 48 579 § 24 40.9 § 2.5 Corticosterone NDb ND 510 § 23 Pregnenolone 628 § 59 47.4 § 5.9 68.8 § 4.0 17-Estradiol 63.2 § 0.5 23.6 § 2.7 51.7 § 3.3 Allopregnanolone 245 § 18 ND 37.8 § 2.1 Estrone ND 17.9 § 0.4 ND 4-Androstene-3,17-dione 122 § 10 ND ND 17-Hydroxypregnenolone 44.8 § 9.7 ND ND Table 3
Kinetic constants of the zebraWsh SULT2 ST1 and ST2 with DHEA, and SULT2 ST3 with corticosterone as substratea
a Data shown represent means § SD derived from three experiments.
Vmax (nmol/min/mg) Km (M) Vmax/Km
SULT2 ST1 (with DHEA) 2.10 § 0.20 102 § 13 0.021
SULT2 ST2 (with DHEA) 2.64 § 0.21 177 § 26 0.015
of the kinetic properties of SULT2 ST2 and ST3 for their
functioning in the homeostasis of hydroxysteroids in
zebra
Wsh. Based on calculated V
max/K
mshown in
Table 3
the catalytic e
Yciency of SULT2 ST1 or ST2 with DHEA
as substrate appeared to be comparable to that of ST3
with corticosterone as substrate.
Developmental stage-dependent expression of the zebra
Wsh
cytosolic SULT2 STs
In vertebrates, steroid hormones, including
mineralo-corticoids, glucomineralo-corticoids, and sex steroids, are known to
play critical roles in the regulation of mineral balance,
glucose homeostasis, and sexual di
Verentiation
[37]
. In
view of their hydroxysteroid-sulfating activity, an
impor-tant question is whether the expression of the newly
iden-tiWed SULT2 ST2 and ST3 correlates with the
development of endocrine system of the zebraWsh. To gain
insight into this issue, RT-PCR was employed to examine
the expression of mRNAs encoding SULT2 ST2 and ST3,
as well as the previously identiWed SULT2 ST1, at
diVer-ent developmdiVer-ental stages. As shown in
Fig. 5
A, the
mRNA encoding SULT2 ST1 was not present in
unfertil-ized eggs and was not expressed until the embryos reached
the neurula/segmentation period (12-hour pf). Thereafter,
the expression of the SULT2 ST1 mRNA continued into
the larval stage onto maturity. For SULT2 ST2, a signi
W-cant level of its coding mRNA was detected in unfertilized
eggs, indicating clearly its maternal origin. Upon
fertiliza-tion, however, no SULT2 ST2 mRNA was detected until
the neurula/segmentation period (12-h pf), which then
increased dramatically when reaching the larval stage
(1-week pf) onto maturity. Both SULT2 ST1 and ST2
mRNAs were detected in adult male and female zebra
Wsh.
It is worthwhile pointing out that DHEA, a major
substrate for both SULT2 ST1 and ST2, occupies an
important position as the biosynthetic precursor for
tes-tosterone and 17-estradiol, as well as other sex steroids
[38]
. It has been reported that DHEA and some other
ste-roids are also produced de novo in the nervous system
where these so-called “neurosteroids” may play important
roles in the regulation of the activity of genes and protein
synthesis, cellular development, and the functioning of
neuroendocrine system and behavioral pattern
[39]
. That
the initiation of the expression of both SULT2 ST1 and
ST2 coincided with the beginning of the development of
the nervous system (at the neurula/segmentation stage)
poses an interesting question whether these two enzymes
are involved in the regulation and/or homeostasis of
DHEA and other neurosteroids. Moreover, since the
expression of SULT2 ST1 and ST2 continues into the
lar-val stage onto maturity, it is also possible that they may
Fig. 5. Developmental stage-dependent expression of the zebraWsh SULT2 STs. (A) RT-PCR analysis of the expression of mRNAs encoding SULT2 ST2 and ST3, as well as the previously identiWed zebraWsh SULT2 ST1, at diVerent stages during embryogenesis and larval development onto maturity. Final PCR mixtures were subjected to 2% agarose electrophoresis. Samples analyzed in lanes 1 through 15 correspond to unfertilized zebraWsh eggs, zebraWsh embryos during the zygote period (0-h post-fertilization (pf)), cleavage period (1-h pf), blastula period (3-h pf), gastrula period (6-h pf), neurula/segmenta-tion period (12-h pf), pharyngula period (24-h pf), and hatching period (48- and 72-h pf), 1, 2, 3, 4-week-old zebraWsh larvae, and 3-month-old male (lane 14) or female (lane 15) zebraWsh. The PCR products corresponding to diVerent zebraWsh SULT2 ST cDNAs, visualized by ethidium bromide staining, are marked by arrows. (B) RT-PCR analysis of the expression of the zebraWsh -actin at the same developmental stages as those described in (A).
3,000 bp 2,000 bp 1,500 bp 1,200 bp 1,031 bp 900 bp
1 2 3 4 5 6 7 8 9 10 11 12
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
A
B
SULT2 ST1
SULT2 ST2
SULT2 ST3
β-Actin
M
13 14 15 M
be involved in the regulation of sex steroids. The
physio-logical relevance of the expression of SULT2 ST2, but not
SULT2 ST1, as a maternal transcript in unfertilized
zebra
Wsh egges remains unclear. For SULT2 ST3, a
sig-ni
Wcant level of its coding message was detected in
unfer-tilized eggs, indicating its maternal origin. During the
embryonic development, there appeared to be an initial
decrease in expression, followed by disappearance during
the blastula (3-h pf) and gastrula period (6-h pf).
Thereaf-ter, the expression of SULT2 ST3 mRNA resumed in the
neurula/segmentation period (12-h pf) and continued into
the larval stage onto maturity. SULT2 ST3 mRNA was
detected in both male and female zebraWsh. The
physio-logical relevance of this unique pattern of developmental
stage-dependent expression of SULT2 ST3 remains to be
clariWed. It is to be noted, however, that corticosterone, a
favorite substrate for SULT2 ST3, is a major
glucocorti-coid in rodents, and the precursor of aldosterone, the
major mineralocorticoid in man
[37]
. In Wsh,
corticoste-rone can also be converted to cortisol
[40]
, which is known
to play an important role in the osmoregulation
[41]
. It is
plausible that SULT2 ST3 may be critical to the
homeo-stasis of corticosterone and therefore the ability of Wsh to
face osmotic challenges, as well as glucose homeostasis.
The expression of SULT2 ST3 in unfertilized eggs and
embryos during early developmental stages may serve to
regulate the corticosteroids of maternal origin, prior to
the development of endocrine organs. In contrast to the
developmental stage-dependent expression of the SULT2
STs,
-actin, housekeeping protein, was found to be
expressed throughout the entire developmental process
(
Fig. 5
B).
To summarize, we have identi
Wed two novel DHEA/
corticosterone-sulfating cytosolic SULT2 STs, designated
as SULT2 ST2 and ST3, which may be involved in
metab-olism and homeostasis of DHEA and cortoicosterone,
respectively, in zebraWsh. Our goal is to obtain a complete
repertoire of the cytosolic SULT enzymes present in
zebraWsh, and this study is part of an overall eVort. As
pointed out earlier, the identiWcation of the various
cyto-solic SULTs and their biochemical characterization is a
prerequisite for using the zebraWsh as a model for a
sys-tematic investigation on fundamental issues regarding
cytosolic SULTs. More works is warranted in order to
achieve this goal.
Acknowledgments
This work was supported in part by a Grant-in-Aid from
the American Heart Association (Texas AYliate) and a
grant (#0542235) from National Science Foundation.
References
[1] G.J. Mulder, W.B. Jakoby, in: G.J. Mulder (Ed.), Conjugation Reac-tions in Drug Metabolism, Taylor and Francis, London, 1990, pp. 107–161.
[2] C. Falany, J.A. Roth, in: E.H. JeVery (Ed.), Human Drug Metabolism: From Molecular Biology to Man, CRC Press, BocaRaton, FL, 1993, pp. 101–115.
[3] R. Weinshilboum, D. Otterness, in: F.C. Kaufmann (Ed.), Conjuga-tion-Deconjugation Reactions in Drug Metabolism and Toxicity, Springer-Verlag, Berlin, 1994, pp. 45–78.
[4] M.H. Kester, E. Kaptein, T.J. Roest, C.H. van Dijk, D. Tibboel, W. Meinl, H. Glatt, M.W. Coughtrie, T.J. Visser, J. Clin. Endocrinol. Metab. 84 (1999) 1357–1364.
[5] T.J. Visser, Acta Med. Austriaca. 23 (1996) 6–10.
[6] R.L. Blanchard, R.R. Freimuth, J. Buck, R.M. Weinshilboum, M.W. Coughtrie, Pharmacogenetics 14 (2004) 199–211.
[7] Y. Yamazoe, K. Nagata, S. Ozawa, R. Kato, Chem. Biol. Interact. 92 (1994) 107–117.
[8] R.M. Weinshilboum, D.M. Otterness, I.A. Aksoy, T.C. Wood, C.T. Her, R.B. Raftogianis, FASEB J. 11 (1997) 3–14.
[9] C.A. Strott, Endocr. Rev. 23 (2002) 703–732.
[10] J.P. Briggs, Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R3–R9.
[11] A.C. Ward, G.J. Lieschke, Front. Biosci. 7 (2002) 827–833.
[12] T. Sugahara, C.-C. Liu, T.G. Pai, P. Collodi, M. Suiko, Y. Sakaki-bara, K. Nishiyama, M.-C. Liu, Eur. J. Biochem. 270 (2003) 2404–2411.
[13] T. Sugahara, C.-C. Liu, G. Carter, T.G. Pai, M.-C. Liu, Arch. Biochem. Biophys. 414 (2003) 67–73.
[14] T. Sugahara, Y.S. Yang, C.-C. Liu, T.G. Pai, M.-C. Liu, Biochem. J. 375 (2003) 785–791.
[15] T. Sugahara, C.-C. Liu, T.G. Pai, M.-C. Liu, Biochem. Biophys. Res. Commun. 300 (2003) 725–730.
[16] S. Yasuda, C.-C. Liu, S. Takahashi, M. Suiko, L. Chen, R. Snow, M.-C. Liu, Biochem. Biophys. Res. Commun. 330 (2005) 219–225. [17] M.-Y. Liu, Y.-S. Yang, T. Sugahara, S. Yasuda, M.-C. Liu, Arch.
Bio-chem. Biophys. 437 (2005) 10–19.
[18] S. Yasuda, A.P. Kumar, M.-Y. Liu, Y. Sakakibara, M. Suiko, L. Chen, M.-C. Liu, FEBS J. 272 (2005) 3828–3837.
[19] K. Yanagisawa, Y. Sakakibara, M. Suiko, Y. Takami, T. Nakayama, H. Nakajima, K. Takayanagi, Y. Natori, M.-C. Liu, Biosci. Biotech-nol. Biochem. 62 (1998) 1037–1040.
[20] F. Sanger, S. Nicklen, A.R. Coulson, Proc. Natl. Acad. Sci. USA 74 (1977) 5463–5467.
[21] M.-C. Liu, F. Lipmann, Proc. Natl. Acad. Sci. USA 81 (1984) 3695–3698. [22] P.H.P. Fernando, A. Karakawa, Y. Sakakibara, H. Ibuki, H. Nakajima,
M.-C. Liu, M. Suiko, Biosc. Biotechnol. Biochem. 5 (1993) 1974–1975. [23] E.-S. Lin, Y.-S. Yang, Biochem. Biophys. Res. Commun. 271 (2000)
818–822.
[24] U.K. Laemmli, Nature 227 (1970) 680–685. [25] M.M. Bradford, Anal. Biochem. 72 (1976) 248–254.
[26] K. Nagata, Y. Yamazoe, Annu. Rev. Pharmacol. Toxicol. 40 (2000) 159–176.
[27] F. Lipmann, Science 128 (1958) 575–580.
[28] M. Negishi, L.G. Pedersen, E. Petrotchenko, S. Shevtsov, A. Gorokhov, Y. Kakuta, L.C. Pedersen, Arch. Biochem. Biophys. 390 (2001) 149–157. [29] W.J. Geese, R.B. Raftogianis, Biochem. Biophys. Res. Commun. 288
(2001) 280–289.
[30] H.J. Chang, M. Zhou, S.X. Lin, J. Steroid Biochem. Mol. Biol. 77 (2001) 159–165.
[31] C.A. Meloche, C.N. Falany, J. Steroid Biochem. Mol. Biol. 77 (2001) 261–269.
[32] P. Labadie, H. Budzinski, Chemosphere 64 (2006) 1274–1286. [33] T.P. Mommsen, M.M. Vijayan, T.W. Moon, Rev. Fish Biol. Fisher. 9
(1999) 211–268.
[34] A.W. Norman, G. Litwack, in: H.B. Jovanovich (Ed.), Steroid Hormones: Chemistry, Biosynthesis and Metabolism in Hormones, Academic Press, Orlando, FL, 1987, pp. 49–100.
[35] W. Zhan, Y. Xu, A.H. Li, J. Zhang, K.W. Schramm, A. Kettrup, Bull. Environ. Contam. Toxicol. 65 (2000) 560–566.
[36] C.M. Foran, B.N. Peterson, W.H. Benson, Comp. Biochem. Physiol. C Toxicol. Pharmacol. 133 (2002) 345–354.
[37] H.-J. Hsu, N.-C. Hsu, M.-C. Hu, B.-C. Chung, Mol. Cell. Endocrinol. 248 (2006) 160–163.
[38] M.-C. Hu, E.F. Chiang, S.-K. Tong, W. Lai, N.-C. Hsu, L.-C. Wang, B.-C. Chung, Mol. Cell. Endocrinol. 171 (2001) 9–14.
[39] E.E. Baulieu, P. Robel, Proc. Natl. Acad. Sci. USA 95 (1998) 4089–4091. [40] T. Sandor, G.P. Winson, I. Chester Jones, I.W. Henderson, B.J.
White-house, J. Endocrinol. 34 (1966) 105–115.
[41] D.H. Evans, J.B. Claiborne (Eds.), The Physiology of Fishes, Taylor & Francis, Boca Raton, FL, 2006.
[42] L.I. Brodskii, V.V. Ivanov, Ya.L. Kalaidzidis, A.M. Leontovich, V.K. Nikolaev, S.I. Feranchuk, V.A. Drachev, Biochemistry (Moscow) 60 (1995) 923–928.
[43] V.K. Nikolaev, A.M. Leontovich, V.A. Drachev, L.I. Brodsky, Bio-chemistry (Moscow) 62 (1997) 578–582.